Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children

NCT04810390 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Bilastine
DRUG: Placebo

Sponsor

Faes Farma, S.A.

Collaborators

[object Object]